Mitochondrial targets for volatile anesthetics against cardiac ischemia-reperfusion injury

Frontiers in Physiology

Volumn 5 AUG, Issue , 2014, Pages

  Agarwal, Bhawana ^a   Stowe, David F ^a,b,c   Dash, Ranjan K ^a,c   Bosnjak, Zeljko J ^a   Camara, Amadou K S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Medical College of Wisconsin and Marquette University   (United States)

Author keywords

Cardiac IR injury; Cardioprotection; Electron transport chain; Isoflurane; Mitochondrial bioenergetics; Volatile anesthetics

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); AMINO ACID; CATION; DESFLURANE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; MICRORNA; MITOCHONDRIAL DNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MULTIENZYME COMPLEX; PORIN; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE; RECEPTOR PROTEIN; SEVOFLURANE; VOLTAGE DEPENDENT ANION CHANNEL;

ARTICLE; BIOENERGY; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG TARGETING; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HOMEOSTASIS; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84906518211     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00341     Document Type: Article

References (190)

1. 2+ and attenuated ADP-induced NADH oxidation by isoflurane: Implications for cardioprotection. Biochim Biophys Acta 1817, 453-465
2. Agarwal, B., Dash, R.K., Stowe, D.F., Bosnjak, Z.J., and Camara, A.K. (2014). Isoflurane modulates cardiac mitochondrial bioenergetics by selectively attenuating respiratory complexes. Biochim Biophys Acta 1837, 354-365
3. 2+ overload and ROS release. Cardiovasc Res 77, 406-415
4. 2+ responses in intact hearts. Am J Physiol Heart Circ Physiol 281, H1508-1523
5. Arrell, D.K., Elliott, S.T., Kane, L.A., Guo, Y., Ko, Y.H., Pedersen, P.L., Robinson, J., Murata, M., Murphy, A.M., Marban, E., and Van Eyk, J.E. (2006). Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res 99, 706-714
6. Baines, C.P., Song, C.X., Zheng, Y.T., Wang, G.W., Zhang, J., Wang, O.L., Guo, Y., Bolli, R., Cardwell, E.M., and Ping, P. (2003). Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 92, 873-880
7. Belhomme, D., Peynet, J., Louzy, M., Launay, J.M., Kitakaze, M., and Menasche, P. (1999). Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 100, II340-344
8. Bernardi, P. (2013). The mitochondrial permeability transition pore: a mystery solved? Front Physiol 4, 1-12
9. Bertaccini, E.J., Trudell, J.R., and Franks, N.P. (2007). The common chemical motifs within anesthetic binding sites. Anesth Analg 104, 318-324
10. Bienengraeber, M., Pellitteri-Hahn, M., Hirata, N., Baye, T.M., Bosnjak, Z.J., and Olivier, M. (2013). Quantitative characterization of changes in the cardiac mitochondrial proteome during anesthetic preconditioning and ischemia. Physiol Genomics 45, 163-170
11. 2+ uptake-independent respiration and redox state in cardiac isolated mitochondria. J Bioenerg Biomembr 45, 203-218
12. Bopassa, J.C., Eghbali, M., Toro, L., and Stefani, E. (2010). A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 298, H16-23
13. 2+ transients, and papillary muscle tension in the cat. Am J Physiol 251, H374-381
14. 2+ exchanger. Circulation 114, I226-232
15. Brookes, P.S., Yoon, Y., Robotham, J.L., Anders, M.W., and Sheu, S.S. (2004). Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287, C817-833
16. Brookes, P.S., Zhang, J., Dai, L., Zhou, F., Parks, D.A., Darley-Usmar, V.M., and Anderson, P.G. (2001). Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy. J Mol Cell Cardiol 33, 69-82
17. Budas, G.R., Churchill, E.N., Disatnik, M.H., Sun, L., and Mochly-Rosen, D. (2010). Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovasc Res 88, 83-92
18. Burwell, L.S., Nadtochiy, S.M., Tompkins, A.J., Young, S., and Brookes, P.S. (2006). Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J 394, 627-634
19. Camara, A.K., Bienengraeber, M., and Stowe, D.F. (2011). Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol 2, 13
20. Camara, A.K., Lesnefsky, E.J., and Stowe, D.F. (2010). Potential therapeutic benefits of strategies directed to mitochondria. Antioxid Redox Signal 13, 279-347
21. Casanovas, A.M., Malmary Nebot, M.F., Courriere, P., and Oustrin, J. (1983). Inhibition of cytochrome oxidase activity by local anaesthetics. Biochem Pharmacol 32, 2715-2719
22. Chakrabarti, A.K., Feeney, K., Abueg, C., Brown, D.A., Czyz, E., Tendera, M., Janosi, A., Giugliano, R.P., Kloner, R.A., Weaver, W.D., Bode, C., Godlewski, J., Merkely, B., and Gibson, C.M. (2013). Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for STsegment elevation myocardial infarction. Am Heart J 165, 509-514 e507
23. Champattanachai, V., Marchase, R.B., and Chatham, J.C. (2008). Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 294, C1509-1520
24. Chen, K., and Rajewsky, N. (2007). The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8, 93-103
25. 2+] loading and myocardial damage in part via mitochondrial KATP channels. Anesthesiology 97, 912-920
26. Chen, Q., Camara, A.K., Stowe, D.F., Hoppel, C.L., and Lesnefsky, E.J. (2007). Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am J Physiol Cell Physiol 292, C137-147
27. Chen, Q., Vazquez, E.J., Moghaddas, S., Hoppel, C.L., and Lesnefsky, E.J. (2003). Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278, 36027-36031
28. Chen, Z., Chua, C.C., Ho, Y.S., Hamdy, R.C., and Chua, B.H. (2001). Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 280, H2313-2320
29. Cheng, Y., Tan, N., Yang, J., Liu, X., Cao, X., He, P., Dong, X., Qin, S., and Zhang, C. (2010a). A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond) 119, 87-95
30. Cheng, Y., Zhu, P., Yang, J., Liu, X., Dong, S., Wang, X., Chun, B., Zhuang, J., and Zhang, C. (2010b). Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 87, 431-439
31. Chiari, P.C., Bienengraeber, M.W., Pagel, P.S., Krolikowski, J.G., Kersten, J.R., and Warltier, D.C. (2005a). Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 102, 102-109
32. Chiari, P.C., Bienengraeber, M.W., Weihrauch, D., Krolikowski, J.G., Kersten, J.R., Warltier, D.C., and Pagel, P.S. (2005b). Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium. Anesthesiology 103, 74-83
33. Clarke, S.J., Mcstay, G.P., and Halestrap, A.P. (2002). Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J Biol Chem 277, 34793-34799
34. Craigen, W.J., and Graham, B.H. (2008). Genetic strategies for dissecting mammalian and Drosophila voltage-dependent anion channel functions. J Bioenerg Biomembr 40, 207-212
35. Crompton, M., Virji, S., and Ward, J.M. (1998). Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur J Biochem 258, 729-735
36. Das, S., Steenbergen, C., and Murphy, E. (2012). Does the voltage dependent anion channel modulate cardiac ischemia-reperfusion injury? Biochim Biophys Acta 1818, 1451-1456
37. Das, S., Wong, R., Rajapakse, N., Murphy, E., and Steenbergen, C. (2008). Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res 103, 983-991
38. De Hert, S.G., Ten Broecke, P.W., Mertens, E., Van Sommeren, E.W., De Blier, I.G., Stockman, B.A., and Rodrigus, I.E. (2002). Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 97, 42-49
39. De Hert, S.G., Turani, F., Mathur, S., and Stowe, D.F. (2005). Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg 100, 1584-1593
40. 2+ signals to mitochondria. Cell Death Differ 19, 267-273
41. Dong, S., Cheng, Y., Yang, J., Li, J., Liu, X., Wang, X., Wang, D., Krall, T.J., Delphin, E.S., and Zhang, C. (2009). MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284, 29514-29525
42. Duchen, M.R. (2004). Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med 25, 365-451
43. Eckenhoff, R.G., and Johansson, J.S. (1997). Molecular interactions between inhaled anesthetics and proteins. Pharmacol Rev 49, 343-367
44. + channel activity. Free Radic Biol Med 40, 469-479
45. + channels. Biochim Biophys Acta 1762, 202-212.
46. Feng, J., Zhu, M., Schaub, M.C., Gehrig, P., Roschitzki, B., Lucchinetti, E., and Zaugg, M. (2008). Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function. Cardiovasc Res 80, 20-29
47. Ferrari, R. (1996). The role of mitochondria in ischemic heart disease. J Cardiovasc Pharmacol 28 Suppl 1, S1-10
48. Fleisher, L.A., Beckman, J.A., Brown, K.A., Calkins, H., Chaikof, E.L., Fleischmann, K.E., Freeman, W.K., Froehlich, J.B., Kasper, E.K., Kersten, J.R., Riegel, B., Robb, J.F., Smith, S.C., Jr., Jacobs, A.K., Adams, C.D., Anderson, J.L., Antman, E.M., Buller, C.E., Creager, M.A., Ettinger, S.M., Faxon, D.P., Fuster, V., Halperin, J.L., Hiratzka, L.F., Hunt, S.A., Lytle, B.W., Nishimura, R., Ornato, J.P., Page, R.L., Tarkington, L.G., and Yancy, C.W. (2007). ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50, 1707-1732
49. Foster, D.B., Ho, A.S., Rucker, J., Garlid, A.O., Chen, L., Sidor, A., Garlid, K.D., and O'rourke, B. (2012). Mitochondrial ROMK channel is a molecular component of mitoKATP. Circ Res 111, 446-454
50. Foster, D.B., Van Eyk, J.E., Marban, E., and O'rourke, B. (2009). Redox signaling and protein phosphorylation in mitochondria: progress and prospects. J Bioenerg Biomembr 41, 159-168
51. Freedman, B.M., Hamm, D.P., Everson, C.T., Wechsler, A.S., and Christian, C.M., 2nd (1985). Enflurane enhances postischemic functional recovery in the isolated rat heart. Anesthesiology 62, 29-33
52. Garesse, R., and Vallejo, C.G. (2001). Animal mitochondrial biogenesis and function: a regulatory cross-talk between two genomes. Gene 263, 1-16
53. Ge, Z.D., Pravdic, D., Bienengraeber, M., Pratt, P.F., Jr., Auchampach, J.A., Gross, G.J., Kersten, J.R., and Warltier, D.C. (2010). Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism. Anesthesiology 112, 73-85
54. Gerstenblith, G. (2004). Derangements in cardiac metabolism in the ischemic state and consequences of reperfusion. Advanced studies in medicine Vol 4 (6B), 464-471
55. Giorgio, V., Von Stockum, S., Antoniel, M., Fabbro, A., Fogolari, F., Forte, M., Glick, G.D., Petronilli, V., Zoratti, M., Szabo, I., Lippe, G., and Bernardi, P. (2013). Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A 110, 5887-5892
56. ATP- and MPTP-dependent mechanism at reperfusion. Am J Physiol Heart Circ Physiol 294, H1497-1500
57. + channels and myocardial preconditioning. Circ Res 84, 973-979
58. Halestrap, A.P. (2010). A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans 38, 841-860
59. ATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 542, 735-741
60. Hausenloy, D.J., Maddock, H.L., Baxter, G.F., and Yellon, D.M. (2002). Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55, 534-543
61. He, B., Xiao, J., Ren, A.J., Zhang, Y.F., Zhang, H., Chen, M., Xie, B., Gao, X.G., and Wang, Y.W. (2011). Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci 18, 22
62. Hemmings, H.C., Jr. (2010). Molecular targets of general anesthetics in the nervous system. Chapter 2, p 11-31: in "Supressing the Mind: Anesthetics Modulation of Memory and Consciousness." Edited by Hudetz A, pearce R. Humana Press Springer
63. Hirata, N., Shim, Y.H., Pravdic, D., Lohr, N.L., Pratt, P.F., Jr., Weihrauch, D., Kersten, J.R., Warltier, D.C., Bosnjak, Z.J., and Bienengraeber, M. (2011). Isoflurane differentially modulates mitochondrial reactive oxygen species production via forward versus reverse electron transport flow: implications for preconditioning. Anesthesiology 115, 531-540
64. Hirose, K., Tsutsumi, Y.M., Tsutsumi, R., Shono, M., Katayama, E., Kinoshita, M., Tanaka, K., and Oshita, S. (2011). Role of the O-linked beta-N-acetylglucosamine in the cardioprotection induced by isoflurane. Anesthesiology 115, 955-962
65. Hodge, T., and Colombini, M. (1997). Regulation of metabolite flux through voltage-gating of VDAC channels. J Membr Biol 157, 271-279
66. Hu, Z.Y., and Liu, J. (2009). Mechanism of cardiac preconditioning with volatile anaesthetics. Anaesth Intensive Care 37, 532-538
67. Imahashi, K., Schneider, M.D., Steenbergen, C., and Murphy, E. (2004). Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res 95, 734-741
68. Jamnicki-Abegg, M., Weihrauch, D., Pagel, P.S., Kersten, J.R., Bosnjak, Z.J., Warltier, D.C., and Bienengraeber, M.W. (2005). Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology 103, 1006-1014
69. Javadov, S., Karmazyn, M., and Escobales, N. (2009). Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther 330, 670-678
70. Javadov, S.A., Clarke, S., Das, M., Griffiths, E.J., Lim, K.H., and Halestrap, A.P. (2003). Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 549, 513-524
71. Jenkins, A., Greenblatt, E.P., Faulkner, H.J., Bertaccini, E., Light, A., Lin, A., Andreasen, A., Viner, A., Trudell, J.R., and Harrison, N.L. (2001). Evidence for a common binding cavity for three general anesthetics within the GABAA receptor. J Neurosci 21, RC136
72. Jiang, M.T., Nakae, Y., Ljubkovic, M., Kwok, W.M., Stowe, D.F., and Bosnjak, Z.J. (2007). Isoflurane activates human cardiac mitochondrial adenosine triphosphate-sensitive K+ channels reconstituted in lipid bilayers. Anesth Analg 105, 926-932
73. Jones, D.A., Andiapen, M., Van-Eijl, T.J., Webb, A.J., Antoniou, S., Schilling, R.J., Ahluwalia, A., and Mathur, A. (2013). The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial. BMJ Open 3
74. Jones, S.P., Zachara, N.E., Ngoh, G.A., Hill, B.G., Teshima, Y., Bhatnagar, A., Hart, G.W., and Marban, E. (2008). Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 117, 1172-1182
75. Jovic, M., Stancic, A., Nenadic, D., Cekic, O., Nezic, D., Milojevic, P., Micovic, S., Buzadzic, B., Korac, A., Otasevic, V., Jankovic, A., Vucetic, M., Velickovic, K., Golic, I., and Korac, B. (2012). Mitochondrial molecular basis of sevoflurane and propofol cardioprotection in patients undergoing aortic valve replacement with cardiopulmonary bypass. Cell Physiol Biochem 29, 131-142
76. Juhaszova, M., Zorov, D.B., Kim, S.H., Pepe, S., Fu, Q., Fishbein, K.W., Ziman, B.D., Wang, S., Ytrehus, K., Antos, C.L., Olson, E.N., and Sollott, S.J. (2004). Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113, 1535-1549
77. Julier, K., Da Silva, R., Garcia, C., Bestmann, L., Frascarolo, P., Zollinger, A., Chassot, P.G., Schmid, E.R., Turina, M.I., Von Segesser, L.K., Pasch, T., Spahn, D.R., and Zaugg, M. (2003). Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebocontrolled, multicenter study. Anesthesiology 98, 1315-1327
78. Kalenka, A., Maurer, M.H., Feldmann, R.E., Kuschinsky, W., and Waschke, K.F. (2006). Volatile anesthetics evoke prolonged changes in the proteome of the left ventricule myocardium: defining a molecular basis of cardioprotection? Acta Anaesthesiol Scand 50, 414-427
79. Karamanlidis, G., Bautista-Hernandez, V., Fynn-Thompson, F., Del Nido, P., and Tian, R. (2011). Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease. Circ Heart Fail 4, 707-713
80. Kersten, J.R., Schmeling, T.J., Hettrick, D.A., Pagel, P.S., Gross, G.J., and Warltier, D.C. (1996). Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology 85, 794-807
81. ATP channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 87, 361-370
82. Kevin, L.G., Novalija, E., Riess, M.L., Camara, A.K., Rhodes, S.S., and Stowe, D.F. (2003). Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg 96, 949-955
83. Kevin, L.G., Novalija, E., and Stowe, D.F. (2005). Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg 101, 1275-1287
84. Kirby, D.M., and Thorburn, D.R. (2008). Approaches to finding the molecular basis of mitochondrial oxidative phosphorylation disorders. Twin Res Hum Genet 11, 395-411
85. Koltchine, V.V., Finn, S.E., Jenkins, A., Nikolaeva, N., Lin, A., and Harrison, N.L. (1999). Agonist gating and isoflurane potentiation in the human gamma-aminobutyric acid type A receptor determined by the volume of a second transmembrane domain residue. Mol Pharmacol 56, 1087-1093
86. Krolikowski, J.G., Bienengraeber, M., Weihrauch, D., Warltier, D.C., Kersten, J.R., and Pagel, P.S. (2005). Inhibition of mitochondrial permeability transition enhances isofluraneinduced cardioprotection during early reperfusion: the role of mitochondrial KATP channels. Anesth Analg 101, 1590-1596
87. Krolikowski, J.G., Weihrauch, D., Bienengraeber, M., Kersten, J.R., Warltier, D.C., and Pagel, P.S. (2006). Role of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo. Can J Anaesth 53, 174-182
88. Lang, X.E., Wang, X., Zhang, K.R., Lv, J.Y., Jin, J.H., and Li, Q.S. (2013). Isoflurane preconditioning confers cardioprotection by activation of ALDH2. PLoS One 8, e52469
89. Lemasters, J.J., and Holmuhamedov, E. (2006). Voltage-dependent anion channel (VDAC) as mitochondrial governator--thinking outside the box. Biochim Biophys Acta 1762, 181-190
90. Lim, K.H., Javadov, S.A., Das, M., Clarke, S.J., Suleiman, M.S., and Halestrap, A.P. (2002). The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol 545, 961-974
91. Liu, B., Tewari, A.K., Zhang, L., Green-Church, K.B., Zweier, J.L., Chen, Y.R., and He, G. (2009). Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target. Biochim Biophys Acta 1794, 476-485
92. 2+ in ischemic newborn myocardium. Anesth Analg 101, 349-355
93. Ljubkovic, M., Mio, Y., Marinovic, J., Stadnicka, A., Warltier, D.C., Bosnjak, Z.J., and Bienengraeber, M. (2007). Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation. Am J Physiol Cell Physiol 292, C1583-1590
94. Ludwig, L.M., Tanaka, K., Eells, J.T., Weihrauch, D., Pagel, P.S., Kersten, J.R., and Warltier, D.C. (2004a). Preconditioning by isoflurane is mediated by reactive oxygen species generated from mitochondrial electron transport chain complex III. Anesth Analg 99, 1308-1315
95. Ludwig, L.M., Weihrauch, D., Kersten, J.R., Pagel, P.S., and Warltier, D.C. (2004b). Protein kinase C translocation and Src protein tyrosine kinase activation mediate isofluraneinduced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. Anesthesiology 100, 532-539
96. Marinovic, J., Bosnjak, Z.J., and Stadnicka, A. (2006). Distinct roles for sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channels in isoflurane-induced protection against oxidative stress. Anesthesiology 105, 98-104
97. Mewton, N., Croisille, P., Gahide, G., Rioufol, G., Bonnefoy, E., Sanchez, I., Cung, T.T., Sportouch, C., Angoulvant, D., Finet, G., Andre-Fouet, X., Derumeaux, G., Piot, C., Vernhet, H., Revel, D., and Ovize, M. (2010). Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol 55, 1200-1205
98. Mio, Y., Uezono, S., and Kitahata, H. (2014). Anesthetic Cardioprotection in Relation to Mitochondria: Basic Science. Curr Pharm Des.
99. Muravyeva, M., Baotic, I., Bienengraeber, M., Lazar, J., Bosnjak, Z.J., Sedlic, F., Warltier, D.C., and Kersten, J.R. (2014). Cardioprotection during diabetes: the role of mitochondrial DNA. Anesthesiology 120, 870-879
100. Murphy, E., and Steenbergen, C. (2008a). Ion transport and energetics during cell death and protection. Physiology (Bethesda) 23, 115-123
101. Murphy, E., and Steenbergen, C. (2008b). Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88, 581-609
102. Murphy, M.P., Echtay, K.S., Blaikie, F.H., Asin-Cayuela, J., Cocheme, H.M., Green, K., Buckingham, J.A., Taylor, E.R., Hurrell, F., Hughes, G., Miwa, S., Cooper, C.E., Svistunenko, D.A., Smith, R.A., and Brand, M.D. (2003). Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. J Biol Chem 278, 48534-48545
103. Murray, J., Taylor, S.W., Zhang, B., Ghosh, S.S., and Capaldi, R.A. (2003). Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem 278, 37223-37230
104. Murry, C.E., Jennings, R.B., and Reimer, K.A. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136
105. Nadtochiy, S.M., Tompkins, A.J., and Brookes, P.S. (2006). Different mechanisms of mitochondrial proton leak in ischaemia/reperfusion injury and preconditioning: implications for pathology and cardioprotection. Biochem J 395, 611-618
106. Neumann, D., Buckers, J., Kastrup, L., Hell, S.W., and Jakobs, S. (2010). Two-color STED microscopy reveals different degrees of colocalization between hexokinase-I and the three human VDAC isoforms. PMC Biophys 3, 4. Nickel, A., Kohlhaas, M., and Maack, C. (2014). Mitochondrial reactive oxygen species production and elimination. J Mol Cell Cardiol 73, 26-33
107. Nicolli, A., Basso, E., Petronilli, V., Wenger, R.M., and Bernardi, P. (1996). Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel. J Biol Chem 271, 2185-2192
108. Nishihara, M., Miura, T., Miki, T., Sakamoto, J., Tanno, M., Kobayashi, H., Ikeda, Y., Ohori, K., Takahashi, A., and Shimamoto, K. (2006). Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am J Physiol Heart Circ Physiol 291, H748-755
109. Nishihara, M., Miura, T., Miki, T., Tanno, M., Yano, T., Naitoh, K., Ohori, K., Hotta, H., Terashima, Y., and Shimamoto, K. (2007). Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol 43, 564-570
110. Novalija, E., Fujita, S., Kampine, J.P., and Stowe, D.F. (1999). Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts. Anesthesiology 91, 701-712
111. Novalija, E., Kevin, L.G., Camara, A.K., Bosnjak, Z.J., Kampine, J.P., and Stowe, D.F. (2003). Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology 99, 421-428
112. Novalija, E., and Stowe, D.F. (1998). Prior preconditioning by ischemia or sevoflurane improves cardiac work per oxygen use in isolated guinea pig hearts after global ischemia. Adv Exp Med Biol 454, 533-542
113. Novalija, E., Varadarajan, S.G., Camara, A.K., An, J., Chen, Q., Riess, M.L., Hogg, N., and Stowe, D.F. (2002). Anesthetic preconditioning: triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol 283, H44-52
114. + channels and their role in cardioprotection. Circ Res 94, 420-432
115. Olson, J., Yan, Y., Kriegel, A., Bai, X., Liang, M., and Bosnjak, Z. (2013). miR-21 knockdown attenuates the cardioprotective effects of isoflurane. The FASEB Journal, (Abstract)
116. Onishi, A., Miyamae, M., Kaneda, K., Kotani, J., and Figueredo, V.M. (2012). Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A. Eur J Pharmacol 675, 40-46
117. Ozcan, C., Bienengraeber, M., Dzeja, P.P., and Terzic, A. (2002). Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol 282, H531-539
118. Ozcan, C., Palmeri, M., Horvath, T.L., Russell, K.S., and Russell, R.R., 3rd (2013). Role of uncoupling protein 3 in ischemia-reperfusion injury, arrhythmias, and preconditioning. Am J Physiol Heart Circ Physiol 304, H1192-1200
119. Pagel, P.S. (2008). Postconditioning by volatile anesthetics: salvaging ischemic myocardium at reperfusion by activation of prosurvival signaling. J Cardiothorac Vasc Anesth 22, 753-765
120. Pagel, P.S., Krolikowski, J.G., Neff, D.A., Weihrauch, D., Bienengraeber, M., Kersten, J.R., and Warltier, D.C. (2006). Inhibition of glycogen synthase kinase enhances isofluraneinduced protection against myocardial infarction during early reperfusion in vivo. Anesth Analg 102, 1348-1354
121. Pagliaro, P., Moro, F., Tullio, F., Perrelli, M.G., and Penna, C. (2011). Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling. Antioxid Redox Signal 14, 833-850
122. ATP channels triggers the preconditioned state by generating free radicals. Circ Res 87, 460-466
123. Penta De Peppo, A., Polisca, P., Tomai, F., De Paulis, R., Turani, F., Zupancich, E., Sommariva, L., Pasqualetti, P., and Chiariello, L. (1999). Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 68, 112-118
124. Piriou, V., Chiari, P., Gateau-Roesch, O., Argaud, L., Muntean, D., Salles, D., Loufouat, J., Gueugniaud, P.Y., Lehot, J.J., and Ovize, M. (2004). Desflurane-induced preconditioning alters calcium-induced mitochondrial permeability transition. Anesthesiology 100, 581-588
125. Porter, K., Medford, H.M., Mcintosh, C.M., and Marsh, S.A. (2012). Cardioprotection requires flipping the 'posttranslational modification' switch. Life Sci 90, 89-98
126. Pravdic, D., Hirata, N., Barber, L., Sedlic, F., Bosnjak, Z.J., and Bienengraeber, M. (2012). Complex I and ATP synthase mediate membrane depolarization and matrix acidification by isoflurane in mitochondria. Eur J Pharmacol 690, 149-157
127. Pravdic, D., Mio, Y., Sedlic, F., Pratt, P.F., Warltier, D.C., Bosnjak, Z.J., and Bienengraeber, M. (2010). Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosolindependent action at reperfusion. Br J Pharmacol 160, 220-232
128. Pravdic, D., Sedlic, F., Mio, Y., Vladic, N., Bienengraeber, M., and Bosnjak, Z.J. (2009). Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway. Anesthesiology 111, 267-274
129. Qian, L.P., Zhu, S.S., Cao, J.L., and Zeng, Y.M. (2005). Isoflurane preconditioning protects against ischemia-reperfusion injury partly by attenuating cytochrome c release from subsarcolemmal mitochondria in isolated rat hearts. Acta Pharmacol Sin 26, 813-820
130. Qiao, S., Xie, H., Wang, C., Wu, X., Liu, H., and Liu, C. (2013). Delayed anesthetic preconditioning protects against myocardial infarction via activation of nuclear factorkappaB and upregulation of autophagy. J Anesth 27, 251-260
131. ATP channel in cardioprotection. Biochim Biophys Acta 1813, 1309-1315
132. Ramakrishna, H., Rehfeldt, K.H., and Pajaro, O.E. (2014). Heart Transplantation- Anesthetic Pharmacology and Perioperative Considerations. Curr Clin Pharmacol (Epub ahead of print)
133. Raphael, J., Abedat, S., Rivo, J., Meir, K., Beeri, R., Pugatsch, T., Zuo, Z., and Gozal, Y. (2006). Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther 318, 186-194
134. Raphael, J., Rivo, J., and Gozal, Y. (2005). Isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase/Akt signalling. Br J Anaesth 95, 756-763
135. + channels via protein kinase A mediates desflurane-induced preconditioning. Anesth Analg 106, 384-391
136. Riess, M.L., Camara, A.K., Chen, Q., Novalija, E., Rhodes, S.S., and Stowe, D.F. (2002a). Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts. Am J Physiol Heart Circ Physiol 283, H53-60
137. Riess, M.L., Camara, A.K., Heinen, A., Eells, J.T., Henry, M.M., and Stowe, D.F. (2008a). KATP channel openers have opposite effects on mitochondrial respiration under different energetic conditions. J Cardiovasc Pharmacol 51, 483-491
138. 2+ overload during ischemia in Guinea pig intact hearts: reversal by 5-hydroxydecanoic acid. Anesth Analg 95, 1540-1546
139. Riess, M.L., Costa, A.D., Carlson, R., Jr., Garlid, K.D., Heinen, A., and Stowe, D.F. (2008b). Differential increase of mitochondrial matrix volume by sevoflurane in isolated cardiac mitochondria. Anesth Analg 106, 1049-1055
140. Riess, M.L., Eells, J.T., Kevin, L.G., Camara, A.K., Henry, M.M., and Stowe, D.F. (2004a). Attenuation of mitochondrial respiration by sevoflurane in isolated cardiac mitochondria is mediated in part by reactive oxygen species. Anesthesiology 100, 498-505
141. Riess, M.L., Kevin, L.G., Mccormick, J., Jiang, M.T., Rhodes, S.S., and Stowe, D.F. (2005). Anesthetic preconditioning: the role of free radicals in sevoflurane-induced attenuation of mitochondrial electron transport in Guinea pig isolated hearts. Anesth Analg 100, 46-53
142. Riess, M.L., Novalija, E., Camara, A.K., Eells, J.T., Chen, Q., and Stowe, D.F. (2003). Preconditioning with sevoflurane reduces changes in nicotinamide adenine dinucleotide during ischemia-reperfusion in isolated hearts: reversal by 5-hydroxydecanoic acid. Anesthesiology 98, 387-395
143. Riess, M.L., Stowe, D.F., and Warltier, D.C. (2004b). Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? Am J Physiol Heart Circ Physiol 286, H1603-1607
144. Rostovtseva, T.K., Tan, W., and Colombini, M. (2005). On the role of VDAC in apoptosis: fact and fiction. J Bioenerg Biomembr 37, 129-142
145. Saotome, M., Katoh, H., Satoh, H., Nagasaka, S., Yoshihara, S., Terada, H., and Hayashi, H. (2005). Mitochondrial membrane potential modulates regulation of mitochondrial Ca2+ in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 288, H1820-1828
146. Sedlic, F., Pravdic, D., Hirata, N., Mio, Y., Sepac, A., Camara, A.K., Wakatsuki, T., Bosnjak, Z.J., and Bienengraeber, M. (2010a). Monitoring mitochondrial electron fluxes using NAD(P)H-flavoprotein fluorometry reveals complex action of isoflurane on cardiomyocytes. Biochim Biophys Acta 1797, 1749-1758
147. Sedlic, F., Pravdic, D., Ljubkovic, M., Marinovic, J., Stadnicka, A., and Bosnjak, Z.J. (2009). Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane. Anesth Analg 109, 405-411
148. Sedlic, F., Sepac, A., Pravdic, D., Camara, A.K., Bienengraeber, M., Brzezinska, A.K., Wakatsuki, T., and Bosnjak, Z.J. (2010b). Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: roles of ROS and Ca2+. Am J Physiol Cell Physiol 299, C506-515
149. Shabalina, I.G., and Nedergaard, J. (2011). Mitochondrial ('mild') uncoupling and ROS production: physiologically relevant or not? Biochem Soc Trans 39, 1305-1309
150. Shimizu, S., Matsuoka, Y., Shinohara, Y., Yoneda, Y., and Tsujimoto, Y. (2001). Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J Cell Biol 152, 237-250
151. Shimizu, S., Narita, M., and Tsujimoto, Y. (1999). Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487
152. Shoshan-Barmatz, V., and Ben-Hail, D. (2012). VDAC, a multi-functional mitochondrial protein as a pharmacological target. Mitochondrion 12, 24-34
153. Stadnicka, A., Marinovic, J., Bienengraeber, M., and Bosnjak, Z.J. (2006). Impact of in vivo preconditioning by isoflurane on adenosine triphosphate-sensitive potassium channels in the rat heart: lasting modulation of nucleotide sensitivity during early memory period. Anesthesiology 104, 503-510
154. Steenbergen, C., Murphy, E., Levy, L., and London, R.E. (1987). Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 60, 700-707
155. Steenbergen, C., Murphy, E., Watts, J.A., and London, R.E. (1990). Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 66, 135-146
156. Stowe, D.F., and Camara, A.K. (2009). Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal 11, 1373-1414
157. Stowe, D.F., and Kevin, L.G. (2004). Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics. Antioxid Redox Signal 6, 439-448
158. Stumpner, J., Lange, M., Beck, A., Smul, T.M., Lotz, C.A., Kehl, F., Roewer, N., and Redel, A. (2012a). Desflurane-induced post-conditioning against myocardial infarction is mediated by calcium-activated potassium channels: role of the mitochondrial permeability transition pore. Br J Anaesth 108, 594-601
159. Stumpner, J., Smul, T.M., Redel, A., Hilz, T., Tischer-Zeitz, T., Eisenbarth, H., Schick, M.A., Kehl, F., Roewer, N., and Lange, M. (2012b). Desflurane-induced and ischaemic postconditioning against myocardial infarction are mediated by Pim-1 kinase. Acta Anaesthesiol Scand 56, 904-913
160. Szabo, I., and Zoratti, M. (1993). The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore. FEBS Lett 330, 201-205
161. Tanaka, K., Ludwig, L.M., Kersten, J.R., Pagel, P.S., and Warltier, D.C. (2004a). Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 100, 707-721
162. Tanaka, K., Ludwig, L.M., Krolikowski, J.G., Alcindor, D., Pratt, P.F., Kersten, J.R., Pagel, P.S., and Warltier, D.C. (2004b). Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. Anesthesiology 100, 525-531
163. Tanaka, K., Weihrauch, D., Kehl, F., Ludwig, L.M., Ladisa, J.F., Jr., Kersten, J.R., Pagel, P.S., and Warltier, D.C. (2002). Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 97, 1485-1490
164. Tanguay, M., Blaise, G., Dumont, L., Beique, G., and Hollmann, C. (1991). Beneficial effects of volatile anesthetics on decrease in coronary flow and myocardial contractility induced by oxygen-derived free radicals in isolated rabbit hearts. J Cardiovasc Pharmacol 18, 863-870
165. 2+-induced mitochondrial permeability transition in rat liver mitochondria. Arch Biochem Biophys 495, 174-181
166. Tonkovic-Capin, M., Gross, G.J., Bosnjak, Z.J., Tweddell, J.S., Fitzpatrick, C.M., and Baker, J.E. (2002). Delayed cardioprotection by isoflurane: role of KATP channels. Am J Physiol Heart Circ Physiol 283, H61-68
167. Tullio, F., Angotti, C., Perrelli, M.G., Penna, C., and Pagliaro, P. (2013). Redox balance and cardioprotection. Basic Res Cardiol 108, 392
168. Van Der Linden, P.J., Daper, A., Trenchant, A., and De Hert, S.G. (2003). Cardioprotective effects of volatile anesthetics in cardiac surgery. Anesthesiology 99, 516-517
169. Vander Heiden, M.G., Chandel, N.S., Li, X.X., Schumacker, P.T., Colombini, M., and Thompson, C.B. (2000). Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc Natl Acad Sci U S A 97, 4666-4671
170. Vinnakota, K.C., Dash, R.K., and Beard, D.A. (2011). Stimulatory effects of calcium on respiration and NAD(P)H synthesis in intact rat heart mitochondria utilizing physiological substrates cannot explain respiratory control in vivo. J Biol Chem 286, 30816-30822
171. Walters, A.M., Porter, G.A., Jr., and Brookes, P.S. (2012). Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ Res 111, 1222-1236
172. Wang, C., Neff, D.A., Krolikowski, J.G., Weihrauch, D., Bienengraeber, M., Warltier, D.C., Kersten, J.R., and Pagel, P.S. (2006a). The influence of B-cell lymphoma 2 protein, an antiapoptotic regulator of mitochondrial permeability transition, on isoflurane-induced and ischemic postconditioning in rabbits. Anesth Analg 102, 1355-1360
173. Wang, C., Weihrauch, D., Schwabe, D.A., Bienengraeber, M., Warltier, D.C., Kersten, J.R., Pratt, P.F., Jr., and Pagel, P.S. (2006b). Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats. Anesth Analg 103, 281-288
174. 2+ during ischemia in rat hearts: role of KATP channels. Am J Physiol Heart Circ Physiol 280, H2321-2328
175. Warltier, D.C., Al-Wathiqui, M.H., Kampine, J.P., and Schmeling, W.T. (1988). Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 69, 552-565
176. Weber, N.C., and Schlack, W. (2008). Inhalational anaesthetics and cardioprotection. Handb Exp Pharmacol, 187-207
177. Weihrauch, D., Krolikowski, J.G., Bienengraeber, M., Kersten, J.R., Warltier, D.C., and Pagel, P.S. (2005). Morphine enhances isoflurane-induced postconditioning against myocardial infarction: the role of phosphatidylinositol-3-kinase and opioid receptors in rabbits. Anesth Analg 101, 942-949
178. Wick, M.J., Mihic, S.J., Ueno, S., Mascia, M.P., Trudell, J.R., Brozowski, S.J., Ye, Q., Harrison, N.L., and Harris, R.A. (1998). Mutations of gamma-aminobutyric acid and glycine receptors change alcohol cutoff: evidence for an alcohol receptor? Proc Natl Acad Sci U S A 95, 6504-6509
179. ATP channel assay. Circ Res 106, 1190-1196.
180. Wong, R., Aponte, A.M., Steenbergen, C., and Murphy, E. (2010). Cardioprotection leads to novel changes in the mitochondrial proteome. Am J Physiol Heart Circ Physiol 298, H75-91
181. Wu, W., Zhou, X., Liu, P., Fei, W., Li, L., and Yun, H. (2014). Isoflurane reduces hypoxia/reoxygenation-induced apoptosis and mitochondrial permeability transition in rat primary cultured cardiocytes. BMC Anesthesiol 14, 17
182. Yang, M., Camara, A.K., Wakim, B.T., Zhou, Y., Gadicherla, A.K., Kwok, W.M., and Stowe, D.F. (2012). Tyrosine nitration of voltage-dependent anion channels in cardiac ischemiareperfusion: reduction by peroxynitrite scavenging. Biochim Biophys Acta 1817, 2049-2059
183. Yin, C., Salloum, F.N., and Kukreja, R.C. (2009). A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circ Res 104, 572-575
184. Zalk, R., Israelson, A., Garty, E.S., Azoulay-Zohar, H., and Shoshan-Barmatz, V. (2005). Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria. Biochem J 386, 73-83
185. Zaugg, M., Lucchinetti, E., Garcia, C., Pasch, T., Spahn, D.R., and Schaub, M.C. (2003a). Anaesthetics and cardiac preconditioning. Part II. Clinical implications. Br J Anaesth 91, 566-576
186. Zaugg, M., Lucchinetti, E., Uecker, M., Pasch, T., and Schaub, M.C. (2003b). Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 91, 551-565
187. Zaugg, M., and Schaub, M.C. (2003). Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning. J Muscle Res Cell Motil 24, 219-249
188. Zhao, Z.Q., Nakamura, M., Wang, N.P., Wilcox, J.N., Shearer, S., Ronson, R.S., Guyton, R.A., and Vinten-Johansen, J. (2000). Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 45, 651-660
189. Zhu, J., Rebecchi, M.J., Tan, M., Glass, P.S., Brink, P.R., and Liu, L. (2010). Age-associated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart. J Gerontol A Biol Sci Med Sci 65, 611-619
190. Zima, A.V., and Blatter, L.A. (2006). Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 71, 310-321